Abstract
Mutations in the WAF1/CIP1 gene were not found in 36 ovarian carcinomas, including tumours with loss of heterozygosity at the WAF1/CIP1 locus and/or lacking p53 mutations. In addition, no association was demonstrable between a polymorphism in a conserved region of the WAF1/CIP1 gene and ovarian carcinoma.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wan, M., Cofer, K. & Dubeau, L. WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer. Br J Cancer 73, 1398–1400 (1996). https://doi.org/10.1038/bjc.1996.265
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.265
- Springer Nature Limited
This article is cited by
-
Polymorphisms in the p53 pathway
Oncogene (2006)
-
Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25
Oncogene (1999)
-
Effects of enhancing p21 waf1 on proliferation and expression of G1cyclins andCDKs in human breast cancer cells
Chinese Science Bulletin (1999)